Sukhi Bansal is a Professor of Chemical Biology in the School of Cancer and Pharmaceutical Sciences at King’s College London (KCL), and the School Lead (Education). Sukhi started his scientific career at the Chemistry Department, University of Strathclyde, pursuing a PhD on the medicinal chemistry of GABA. His postdoctoral training on muscarinic receptors biochemistry started at the MRC National Institute for Medical Research in London with Ed Hume and Nigel Birdsall and he then continued with Bob Sheppard at MRC Laboratory for Medical Research in Cambridge on peptide chemistry before joining KCL. Since 1989 Sukhi has led the peptide group at KCL, which has focused on developing peptide chemistry and analytical methodologies in particular mass spectrometry. In recent years the focus of his research has been on hepcidin, a biomarker for iron metabolism. Sukhi’s research has developed analytical methods for the measurement of hepcidin in a wide range of patient population and has been involved with a number of clinical trial with both industry and academia.